What is the current annual SG&A of EXAS?

As of today, EXAS annual SG&A is $0.00

What is 1-year change in EXAS annual SG&A?

EXAS annual SG&A is down -100.00% year-over-year

What is 3-year change in EXAS annual SG&A?

EXAS annual SG&A is down -100.00% over the past 3 years

How far is EXAS annual SG&A from its all-time high?

EXAS annual SG&A is currently -100.00% below its historical high of $1.66B set on December 31, 2021

How does EXAS annual SG&A rank versus sector peers?

EXAS annual SG&A is higher than 39.37% of companies in Healthcare sector

When is EXAS next annual earnings release?

The next annual earnings release for EXAS is on February 25, 2026

What is the current quarterly SG&A of EXAS?

As of today, EXAS quarterly SG&A is $0.00

What is EXAS quarterly SG&A most recent change?

EXAS quarterly SG&A was down -100.00% on September 30, 2025

What is 1-year change in EXAS quarterly SG&A?

EXAS quarterly SG&A is down -100.00% year-over-year

How far is EXAS quarterly SG&A from its all-time high?

EXAS quarterly SG&A is currently -100.00% below its historical high of $485.00M set on March 31, 2025

How does EXAS quarterly SG&A rank versus sector peers?

EXAS quarterly SG&A is higher than 45.89% of companies in Healthcare sector

When is EXAS next earnings release?

The next earnings release for EXAS is on February 25, 2026

What is the current TTM SG&A of EXAS?

As of today, EXAS TTM SG&A is -$18.32B

What is EXAS TTM SG&A most recent change?

EXAS TTM SG&A was down -5.69% on September 30, 2025

What is 1-year change in EXAS TTM SG&A?

EXAS TTM SG&A is down -1213.21% year-over-year

How does EXAS TTM SG&A rank versus sector peers?

EXAS TTM SG&A is higher than 1.11% of companies in Healthcare sector

When is EXAS next earnings release?

The next earnings release for EXAS is on February 25, 2026

EXAS SG&A History & Chart Since 1997

Annual SG&A

$0.00$1.62B-100.00%

December 31, 2024

Summary

Current Value: As of today, EXAS annual SG&A is $0.00, down -100.00% on December 31, 2024
Historical Performance: EXAS annual SG&A is down -100.00% over the past 3 years, and down -100.00% over the past 5 years
All-Time High Comparison: EXAS annual SG&A is currently -100.00% below its historical high of $1.66B set on December 31, 2021
3-Year Low Comparison: EXAS annual SG&A vs 3-year low value is unknown
Sector Comparison: EXAS annual SG&A is higher than 39.37% of companies in Healthcare sector

SG&A Chart

Add series to chart

Add series to chart1/6

Company, ETF, index, screener or watchlist

Series

Performance

EXAS Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual SG&A	Dec 31, 24	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
Quarterly SG&A	Sep 30, 25	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
TTM SG&A	Sep 30, 25	-$18.32B	-1213.2%	-1215.0%	-1889.5%	-10000.0%
Price	Jan 9, 26	$102.11	+80.2%	+73.6%	-22.1%	+1585.0%
Annual Operating Expenses	Dec 31, 24	$2.11B	+2.2%	+8.7%	+159.1%	+10000.0%
Annual Operating Profit	Dec 31, 24	-$191.79M	+38.3%	+73.7%	-12.2%	-2195.5%
Annual D&A	Dec 31, 24	$214.86M	-8.4%	+4.2%	+285.9%	+10000.0%
Annual Revenue	Dec 31, 24	$2.76B	+10.4%	+56.1%	+214.8%	+10000.0%

SG&A Highs

EXAS Annual SG&A Highs Comparison
Period	High	Date	Current
3Y	$1.62B	Dec 31, 23	-100.0%
5Y	$1.66B	Dec 31, 21	-100.0%
All	$1.66B	Dec 31, 21	-100.0%

SG&A Lows

EXAS Annual SG&A Lows Comparison
Period	Low	Date	Current
3Y	$0.00	Dec 31, 24	N/A
5Y	$0.00	Dec 31, 24	N/A
All	$0.00	Dec 31, 24	N/A

SG&A History

Year	Value	Change
2024	$0.00	-100.0%
2023	$1.62B	+2.3%
2022	$1.58B	-4.8%
2021	$1.66B	+55.2%
2020	$1.07B	+45.2%
2019	$737.63M	+72.4%
2018	$427.74M	+62.7%
2017	$262.96M	+38.6%
2016	$189.72M	+35.4%
2015	$140.09M	+102.0%
2014	$69.34M	+198.5%
2013	$23.23M	+58.5%
2012	$14.66M	+33.3%
2011	$10.99M	+35.3%

Year	Value	Change
2010	$8.12M	-9.5%
2009	$8.98M	+38.7%
2008	$6.47M	-24.2%
2007	$8.53M	-20.3%
2006	$10.70M	-1.4%
2005	$10.85M	-11.4%
2004	$12.24M	-16.3%
2003	$14.63M	+24.6%
2002	$11.74M	+29.4%
2001	$9.08M	+88.6%
2000	$4.81M	+208.5%
1999	$1.56M	+33.3%
1998	$1.17M	+43.7%
1997	$814.40K	-

FAQ

What is the current annual SG&A of EXAS?
As of today, EXAS annual SG&A is $0.00
What is 1-year change in EXAS annual SG&A?
EXAS annual SG&A is down -100.00% year-over-year
What is 3-year change in EXAS annual SG&A?
EXAS annual SG&A is down -100.00% over the past 3 years
How far is EXAS annual SG&A from its all-time high?
EXAS annual SG&A is currently -100.00% below its historical high of $1.66B set on December 31, 2021
How does EXAS annual SG&A rank versus sector peers?
EXAS annual SG&A is higher than 39.37% of companies in Healthcare sector
When is EXAS next annual earnings release?
The next annual earnings release for EXAS is on February 25, 2026

Quarterly SG&A

$0.00$455.70M-100.00%

September 30, 2025

Summary

Current Value: As of today, EXAS quarterly SG&A is $0.00, down -100.00% on September 30, 2025
Historical Performance: EXAS quarterly SG&A is down -100.00% year-over-year, and down -100.00% over the past 3 years
All-Time High Comparison: EXAS quarterly SG&A is currently -100.00% below its historical high of $485.00M set on March 31, 2025
3-Year Low Comparison: EXAS quarterly SG&A vs 3-year low value is unknown
Sector Comparison: EXAS quarterly SG&A is higher than 45.89% of companies in Healthcare sector

Performance

EXAS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly SG&A	Sep 30, 25	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
Annual SG&A	Dec 31, 24	$0.00	–	-100.0%	-100.0%	-100.0%
TTM SG&A	Sep 30, 25	-$18.32B	-1124.4%	-1213.2%	-1215.0%	-1889.5%
Price	Jan 9, 26	$102.11	+71.7%	+80.2%	+73.6%	-22.1%
Quarterly Operating Expenses	Sep 30, 25	$567.65M	+1.4%	+9.7%	+19.2%	+100.2%
Quarterly Operating Profit	Sep 30, 25	$16.28M	+489.5%	+155.9%	+113.0%	+157.2%
Quarterly D&A	Sep 30, 25	$55.88M	+1.1%	+2.0%	+0.3%	+18.1%
Quarterly Revenue	Sep 30, 25	$850.74M	+4.9%	+20.1%	+62.6%	+108.3%

Quarterly SG&A Highs

EXAS Quarterly SG&A Highs Comparison
Period	High	Date	Current
1Y	$485.00M	Mar 31, 25	-100.0%
3Y	$485.00M	Mar 31, 25	-100.0%
5Y	$485.00M	Mar 31, 25	-100.0%
All	$485.00M	Mar 31, 25	-100.0%

Quarterly SG&A Lows

EXAS Quarterly SG&A Lows Comparison
Period	Low	Date	Current
1Y	$0.00	Sep 30, 25	N/A
3Y	$0.00	Sep 30, 25	N/A
5Y	$0.00	Sep 30, 25	N/A
All	$0.00	Mar 1, 99	N/A

Quarterly SG&A History

Month	Value	Change
Sep 2025	$0.00	-100.0%
Jun 2025	$455.70M	-6.0%
Mar 2025	$485.00M	+11.3%
Dec 2024	$435.64M	+5.8%
Sep 2024	$411.85M	+6.4%
Jun 2024	$387.13M	-11.1%
Mar 2024	$435.48M	+5.9%
Dec 2023	$411.03M	+5.2%
Sep 2023	$390.55M	-5.8%
Jun 2023	$414.46M	+2.5%
Mar 2023	$404.26M	+0.0%
Dec 2022	$404.11M	+6.4%
Sep 2022	$379.67M	-4.5%
Jun 2022	$397.59M	-1.1%
Mar 2022	$401.95M	-13.3%
Dec 2021	$463.67M	+21.0%
Sep 2021	$383.16M	+5.7%
Jun 2021	$362.46M	-20.1%
Mar 2021	$453.87M	+45.5%
Dec 2020	$311.96M	+23.8%
Sep 2020	$252.07M	+11.8%
Jun 2020	$225.55M	-19.9%
Mar 2020	$281.74M	+6.6%
Dec 2019	$264.27M	+58.5%
Sep 2019	$166.73M	+9.8%
Jun 2019	$151.91M	-1.8%
Mar 2019	$154.75M	+16.2%
Dec 2018	$133.21M	+19.4%
Sep 2018	$111.57M	+18.7%
Jun 2018	$94.00M	+5.6%
Mar 2018	$88.98M	+19.6%
Dec 2017	$74.37M	+8.5%
Sep 2017	$68.53M	+11.7%
Jun 2017	$61.34M	+4.2%
Mar 2017	$58.87M	+13.2%
Dec 2016	$52.00M	+11.6%
Sep 2016	$46.60M	-2.1%
Jun 2016	$47.59M	+9.3%
Mar 2016	$43.54M	+15.1%
Dec 2015	$37.81M	-1.8%
Sep 2015	$38.51M	+12.4%
Jun 2015	$34.28M	+16.2%
Mar 2015	$29.50M	+14.8%
Dec 2014	$25.69M	+15.7%
Sep 2014	$22.21M	+79.2%
Jun 2014	$12.40M	+37.1%
Mar 2014	$9.04M	+37.2%
Dec 2013	$6.59M	+24.3%
Sep 2013	$5.30M	-23.5%
Jun 2013	$6.93M	+57.2%
Mar 2013	$4.41M	-5.0%
Dec 2012	$4.64M	+30.6%
Sep 2012	$3.55M	-4.6%

Month	Value	Change
Jun 2012	$3.72M	+36.0%
Mar 2012	$2.74M	+11.9%
Dec 2011	$2.45M	-11.5%
Sep 2011	$2.77M	+11.5%
Jun 2011	$2.48M	+1.4%
Mar 2011	$2.45M	-10.1%
Dec 2010	$2.72M	+28.9%
Sep 2010	$2.11M	+26.5%
Jun 2010	$1.67M	+3.0%
Mar 2010	$1.62M	-9.9%
Dec 2009	$1.80M	+20.8%
Sep 2009	$1.49M	-11.2%
Jun 2009	$1.68M	-64.8%
Mar 2009	$4.77M	+155.2%
Dec 2008	$1.87M	+47.0%
Sep 2008	$1.27M	-15.0%
Jun 2008	$1.50M	-18.5%
Mar 2008	$1.84M	-7.0%
Dec 2007	$1.97M	-26.2%
Sep 2007	$2.68M	+44.8%
Jun 2007	$1.85M	-9.3%
Mar 2007	$2.04M	-0.9%
Dec 2006	$2.06M	-25.3%
Sep 2006	$2.75M	-0.7%
Jun 2006	$2.77M	-11.4%
Mar 2006	$3.13M	+30.7%
Dec 2005	$2.39M	-4.5%
Sep 2005	$2.51M	-11.4%
Jun 2005	$2.83M	-9.4%
Mar 2005	$3.12M	-3.9%
Dec 2004	$3.25M	+7.9%
Sep 2004	$3.01M	+5.6%
Jun 2004	$2.85M	-16.6%
Mar 2004	$3.42M	-10.2%
Dec 2003	$3.81M	+7.1%
Sep 2003	$3.56M	-7.0%
Jun 2003	$3.82M	+11.1%
Mar 2003	$3.44M	+20.0%
Dec 2002	$2.87M	-2.4%
Sep 2002	$2.94M	+16.0%
Jun 2002	$2.53M	+10.7%
Mar 2002	$2.29M	>+9,900.0%
Dec 2001	$0.00	-100.0%
Sep 2001	$1.96M	-24.6%
Jun 2001	$2.61M	+0.9%
Mar 2001	$2.58M	>+9,900.0%
Dec 2000	$0.00	0.0%
Sep 2000	$0.00	0.0%
Jun 2000	$0.00	0.0%
Mar 2000	$0.00	0.0%
Dec 1999	$0.00	0.0%
Sep 1999	$0.00	0.0%
Mar 1999	$0.00	-

FAQ

What is the current quarterly SG&A of EXAS?
As of today, EXAS quarterly SG&A is $0.00
What is EXAS quarterly SG&A most recent change?
EXAS quarterly SG&A was down -100.00% on September 30, 2025
What is 1-year change in EXAS quarterly SG&A?
EXAS quarterly SG&A is down -100.00% year-over-year
How far is EXAS quarterly SG&A from its all-time high?
EXAS quarterly SG&A is currently -100.00% below its historical high of $485.00M set on March 31, 2025
How does EXAS quarterly SG&A rank versus sector peers?
EXAS quarterly SG&A is higher than 45.89% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on February 25, 2026

TTM SG&A

-$18.32B$986.58M-5.69%

September 30, 2025

Summary

Current Value: As of today, EXAS TTM SG&A is -$18.32B, down -5.69% on September 30, 2025
Historical Performance: EXAS TTM SG&A is down -1213.21% year-over-year, and down -1214.98% over the past 3 years
All-Time High Comparison: EXAS TTM SG&A is currently -101665.21% below its historical high of -$18.00M set on an earlier date
3-Year Low Comparison: EXAS TTM SG&A is at its 3-year low
Sector Comparison: EXAS TTM SG&A is higher than 1.11% of companies in Healthcare sector

Performance

EXAS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM SG&A	Sep 30, 25	-$18.32B	-1124.4%	-1213.2%	-1215.0%	-1889.5%
Annual SG&A	Dec 31, 24	$0.00	–	-100.0%	-100.0%	-100.0%
Quarterly SG&A	Sep 30, 25	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
Price	Jan 9, 26	$102.11	+71.7%	+80.2%	+73.6%	-22.1%
TTM Operating Profit	Sep 30, 25	-$120.78M	+27.3%	+49.2%	+82.2%	+42.3%
TTM D&A	Sep 30, 25	$218.37M	+0.5%	-2.0%	-3.0%	+33.6%
TTM Revenue	Sep 30, 25	$3.08B	+4.8%	+14.5%	+53.7%	+133.4%

TTM SG&A Highs

EXAS TTM SG&A Highs Comparison
Period	High	Date	Current
1Y	-$15.31B	N/A	-19.7%
3Y	-$12.21B	N/A	-50.0%
5Y	-$6.11B	N/A	-199.6%
All	-$18.00M	N/A	>-9999.0%

TTM SG&A Lows

EXAS TTM SG&A Lows Comparison
Period	Low	Date	Current
1Y	-$18.32B	N/A	at low
3Y	-$18.32B	N/A	at low
5Y	-$18.32B	N/A	at low
All	-$18.32B	N/A	at low

TTM SG&A History

Month	Value	Change
Sep 2025	$1.38B	-23.0%
Jun 2025	$1.79B	+4.0%
Mar 2025	$1.72B	+3.0%
Dec 2024	$1.67B	+1.5%
Sep 2024	$1.65B	+1.3%
Jun 2024	$1.62B	-1.7%
Mar 2024	$1.65B	+1.9%
Dec 2023	$1.62B	+0.4%
Sep 2023	$1.61B	+0.7%
Jun 2023	$1.60B	+1.1%
Mar 2023	$1.59B	+0.1%
Dec 2022	$1.58B	-3.6%
Sep 2022	$1.64B	-0.2%
Jun 2022	$1.65B	+2.2%
Mar 2022	$1.61B	-3.1%
Dec 2021	$1.66B	+10.0%
Sep 2021	$1.51B	+9.5%
Jun 2021	$1.38B	+11.0%
Mar 2021	$1.24B	+16.1%
Dec 2020	$1.07B	+4.7%
Sep 2020	$1.02B	+9.1%
Jun 2020	$938.29M	+8.5%
Mar 2020	$864.65M	+17.2%
Dec 2019	$737.66M	+21.6%
Sep 2019	$606.60M	+10.0%
Jun 2019	$551.43M	+11.7%
Mar 2019	$493.51M	+15.4%
Dec 2018	$427.74M	+15.9%
Sep 2018	$368.90M	+13.2%
Jun 2018	$325.87M	+11.1%
Mar 2018	$293.21M	+11.4%
Dec 2017	$263.11M	+9.3%
Sep 2017	$240.74M	+10.0%
Jun 2017	$218.81M	+6.7%
Mar 2017	$205.06M	+8.1%
Dec 2016	$189.72M	+8.1%
Sep 2016	$175.53M	+4.8%
Jun 2016	$167.44M	+8.6%
Mar 2016	$154.13M	+10.0%
Dec 2015	$140.09M	+9.5%
Sep 2015	$127.98M	+14.6%
Jun 2015	$111.68M	+24.4%
Mar 2015	$89.80M	+29.5%
Dec 2014	$69.34M	+38.0%
Sep 2014	$50.24M	+50.7%
Jun 2014	$33.33M	+19.6%
Mar 2014	$27.86M	+20.0%
Dec 2013	$23.23M	+9.2%
Sep 2013	$21.28M	+9.0%
Jun 2013	$19.53M	+19.6%
Mar 2013	$16.32M	+11.4%
Dec 2012	$14.66M	+17.6%
Sep 2012	$12.46M	+6.7%

Month	Value	Change
Jun 2012	$11.68M	+11.9%
Mar 2012	$10.43M	+2.9%
Dec 2011	$10.14M	-2.6%
Sep 2011	$10.42M	+6.7%
Jun 2011	$9.76M	+9.1%
Mar 2011	$8.95M	+10.2%
Dec 2010	$8.12M	+12.8%
Sep 2010	$7.20M	+9.4%
Jun 2010	$6.58M	-0.1%
Mar 2010	$6.59M	-32.3%
Dec 2009	$9.74M	-0.7%
Sep 2009	$9.80M	+2.3%
Jun 2009	$9.59M	+1.9%
Mar 2009	$9.40M	+45.3%
Dec 2008	$6.47M	-1.6%
Sep 2008	$6.57M	-17.6%
Jun 2008	$7.98M	-4.2%
Mar 2008	$8.33M	-2.4%
Dec 2007	$8.53M	-1.0%
Sep 2007	$8.61M	-0.9%
Jun 2007	$8.69M	-9.6%
Mar 2007	$9.61M	-10.2%
Dec 2006	$10.70M	-3.1%
Sep 2006	$11.04M	+2.3%
Jun 2006	$10.79M	-0.5%
Mar 2006	$10.85M	+0.0%
Dec 2005	$10.85M	-7.3%
Sep 2005	$11.71M	-4.2%
Jun 2005	$12.21M	-0.2%
Mar 2005	$12.24M	-2.4%
Dec 2004	$12.53M	-4.3%
Sep 2004	$13.09M	-4.0%
Jun 2004	$13.64M	-6.6%
Mar 2004	$14.61M	-0.2%
Dec 2003	$14.63M	+6.9%
Sep 2003	$13.69M	+4.7%
Jun 2003	$13.08M	+10.9%
Mar 2003	$11.79M	+10.8%
Dec 2002	$10.63M	+37.0%
Sep 2002	$7.76M	+14.4%
Jun 2002	$6.79M	-1.0%
Mar 2002	$6.86M	-4.1%
Dec 2001	$7.15M	0.0%
Sep 2001	$7.15M	+37.9%
Jun 2001	$5.19M	+100.9%
Mar 2001	$2.58M	>+9,900.0%
Dec 2000	$0.00	0.0%
Sep 2000	$0.00	0.0%
Jun 2000	$0.00	0.0%
Mar 2000	$0.00	0.0%
Dec 1999	$0.00	0.0%
Sep 1999	$0.00	0.0%
Mar 1999	$0.00	-

FAQ

What is the current TTM SG&A of EXAS?
As of today, EXAS TTM SG&A is -$18.32B
What is EXAS TTM SG&A most recent change?
EXAS TTM SG&A was down -5.69% on September 30, 2025
What is 1-year change in EXAS TTM SG&A?
EXAS TTM SG&A is down -1213.21% year-over-year
How does EXAS TTM SG&A rank versus sector peers?
EXAS TTM SG&A is higher than 1.11% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on February 25, 2026

Selling, General & Administrative Expenses Formula

SG&A = − − R&D

Data Sources & References

EXAS Official Website www.exactsciences.com
Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1124140/000112414025000091/0001124140-25-000091-index.htm
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1124140/000112414025000020/0001124140-25-000020-index.htm
EXAS Profile on Yahoo Finance finance.yahoo.com/quote/EXAS
EXAS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exas